HBOT Conversations:
Dr. Hemal Mehta & Fasting (Part 1)
Dr. Hemal Mehta, MD is a Medical Director and an Independent Medical Examiner who focuses on pain management through a Regenerative medicine approach.
Dr. Mehta is Board Certified in Physical Medicine and Pain Management. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. He is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare: Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics.
Dr. Mehta is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University.
Dr. Mehta has extensive experience with stem cell proliferation, and angiogenesis. He has incorporated Ozone Injection Therapy, PRP (Platelet-Rich Plasma) Injections, Hyperbaric Oxygen Therapy and Regenerative Matrix and Regenerative Medicine Procedures – to name a few – into his integrative wellness & longevity medical practices.
Watch the Podcast
HBOT News Network welcomes Dr. Hemal V. Mehta, M.D.; Medical Director of Vibrant Health of North Carolina.
After the first 10-15 years of his medical career focusing on interventional pain management, Dr. Mehta started to get involved in regenerative medicine. Regenerative medicines is a newer field of medicine involving PRP – Platelet Rich Plasma, stem cells, and different techniques (like HBOT) to help regenerate tissue in the body. When he first started using regenerative medicine, Dr. Mehta witnessed his patients doing considerably better and improving to the point that he was able to even wean them off of opioid pain medications. It was then that Dr. Mehta started integrating Hyperbaric Oxygen Therapy (HBOT or HBO Therapy) into some of the individualized patient healing plans he would develop for optimum healing.
Dr. Mehta touches on inflammation and how inflammation is one of the greatest problems people today deal with on a daily basis. Bad food choices, injuries and even stress all contributes to an increase of inflammation. Targeting inflammation is key to a healthy body and mind. Hyperbaric oxygen is an ideal therapy to address inflammation by upregulating the anti-inflammatory gene and downregulating the inflammatory gene. Dr. Mehta also mentions other therapies that assist in reducing inflammation in the joints and body — regenerative treatments using stem cells, PRP, ozone injections and exosomes.
According to Dr. Mehta, too much focus and energy goes into the promotion of pharmaceutical drugs to ease every ailment, indication or condition. He mentioned that when he was studying for his medical degree, he had almost two years of pharmacology classes but only one six-week semester of nutrition. It’s unfortunate that nutrition is not stressed more to young doctors, because much of the food we purchase at the grocery store is toxic and very pro-inflammatory. Dr. Mehta stresses that “you are what you eat”. Processed food is one of the worst things for our bodies. In his opinion, processed food is a major oxygen depleter since our bodies have to use extra energy and oxygen to break it down. Our bodies have to work much harder to break down processed junk, so he encourages our viewers to eat foods that are natural and avoid processed.
Since nutrition is a HUGE part of a person’s health, it’s important to look at alternatives to pharmaceutical drugs – like Hyperbaric Oxygen Therapy and fasting. In Dr. Mehta’s opinion, fasting is an excellent way for people to maintain health. Our bodies don’t necessarily NEED 3 meals a day, so when we overeat our bodies store the excess. Dr. Mehta is a big believer in fasting and reminds us that fasting is the ultimate detox. Food, especially processed food, sugar, and food with high fructose corn syrup, can be very pro-inflammatory and toxic. Fasting accelerates the process of the liver cleaning out toxins and gives our organs a much needed break to heal and rejuvenate. Fasting dates back to the Bible and beyond – every religious facet has fasting as part of their religion.
Fasting is nothing new, so try it and add Hyperbaric Oxygen Therapy into the mix too; something magical is truly happening to the body when you fast and receive HBOT. Dr. Mehta reminds us that there is also a strong association between fasting and reduced cancer risk, which he will get into more in Part 2 of our Conversations with Dr. Mehta about fasting & HBOT. Stay tuned to learn more about how fasting starves the cancer cells from the sugars and nutrients they need to feed and grow.
*Pease consult your doctor to see if fasting is right for you.
Guest
Dr. Hemal Mehta
Dr. Hemal Mehta specializes in non-opioid treatment for joint pain, osteoarthritis, spine pain and neuropathy. He is a board-certified Physical Medicine and Rehabilitation physician whose goal for patients is to reduce pain while increasing their level of function & quality of life. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina.
Dr. Mehta is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare: Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. He is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. He is a member of the American Academy of Physical Medicine & Rehabilitation, American Society of Interventional Pain Physicians, and American Association of Neuromuscular and Electrodiagnostic Medicine.
Dr. Mehta has extensive experience with stem cell proliferation and angiogenesis. For years he has incorporated Hyperbaric Oxygen Therapy into his integrative approach for pain management and rehabilitation, and he has also preformed the following procedures fluoroscopically: Translaminar Cervical and Lumbar ESI, Transforaminal Lumbar ESI, Lumbar Selective Nerve Root Blocks, Stellate Ganglion Blocks, Lumbar Sympathetic Blocks, SIJ injections, Hip Joint Injections, Piriformis Injections, Cervical and Lumbar Facet Joint Injections, Medial Branch Nerve Blocks, Radiofrequency Ablation of Medial Branch Nerve, Discography, Percutaneous Disc Decompression/ Intradiscal Injections, Spinal Cord Stimulator Lead Trial, PRP/ Regenerative Matrix/ Regenerative Medicine Procedures for Spine, Peripheral Joints, and Nerves, P-Shot/O-shot, Juvederm Anti-aging, and Ozone Injection Therapy.
Subscribe Now, It’s Free!
Recent HBOT News
The wound/burn guidelines – 3: Guidelines for the diagnosis and treatment for diabetic ulcer/gangrene.
Abstract: We aimed to prepare guidelines for the management of diabetic ulcer/gangrene with emphasis on the diagnosis and treatment of skin symptoms. They serve as a tool to improve the quality of the diagnosis and treatment in each patient and, further, to improve...
Clinical Trial – HBOT Global Functioning After Stroke
Stroke is one of the leading causes of disability and death in North America and Europe. Up
to 30% of stroke survivors never recuperate completely and suffer from loss of function and
poor quality of life. To improve recovery after stroke, innovative interventions should be a
priority.
Hyperbaric oxygen therapy (HBOT) is an intermittent inhalation of 100% oxygen in a hyperbaric
chamber at a pressure higher than 1 absolute atmosphere (ATA). There is a growing body of
evidence that HBOT can enhance ability of brain to changes its structure (neuroplasticity) in
order to recover. Exercise program during HBOT can augment the effect. Although, recent
randomized controlled trials in patients with chronic brain injury showed promising results,
there are no studies demonstrating combine effect HBOT and exercise rehabilitation program on
stroke recovery.
The proposed study investigates feasibility, safety and efficacy of using a combination of
HBOT and exercise program to improve arm function recovery in chronic stroke patients. In
this pilot randomized control trial, investigators will compare the combination of HBOT and
the focused rehabilitation exercise program versus exercise program alone on recovery of arm
function in patients with chronic stroke.
Clinical Trial – Hyperbaric Oxygen Therapy and Acute Kidney Injury
Kidney injury is a serious complication of cardiac surgery that occurs in up to 30% of
patients and increases the risk of adverse outcomes. Kidney injury initiates when oxygen
supply to the kidney drops below levels that are needed for normal cellular function, causing
tissue oxygen deficiency (hypoxia), activation of the inflammatory cascade, and oxidative
stress. Together, these events further impair tissue oxygenation, culminating in impaired
kidney function due to cellular injury and death.
There are no effective therapies for kidney injury after cardiac surgery, but there is
evidence that recovery is possible if the processes of injury – i.e., impaired oxygen
delivery, increased inflammatory response, and oxidative stress – are ameliorated soon after
the onset of injury. Hyperbaric oxygen therapy (HBOT) – which entails the intermittent
inhalation of 100% oxygen in a hyperbaric chamber at a pressure higher than one absolute
atmosphere (> 760 mmHg) – has been shown to positively affect all of these processes (i.e.,
to improve tissue oxygenation, reduce inflammation, and reduce oxidative stress). Thus, we
hypothesized that HBOT will reduce the severity of kidney injury after cardiac surgery if it
is initiated soon after onset of injury. This hypothesis has not been tested in humans, but
is supported by animal studies.
In this first-in-human, unblinded, controlled pilot trial, 20 adult patients who develop
severe kidney injury soon after cardiac surgery will be randomized (after obtaining informed
consent from the patient or surrogate) to standard-of-care or early HBOT. Severe kidney
injury will be defined as a ≥30% drop in kidney function within 6 hours of surgery (as
determined by change in creatinine from before surgery to Intensive Care Unit (ICU)
admission). This degree of injury occurs in ~ 2% of patients and is associated with a 12-fold
increase in the risk of complete kidney failure (requiring dialysis) or death. Patients will
be excluded if they have any relative or absolute contraindications to HBOT (e.g., severe
ventricular dysfunction, ventricular assist device, severe respiratory dysfunction,
pneumothorax, bronchospasm).